Kymera Therapeutics Inc (KYMR)

Investing Cash Flow

$20.05M

Quarterly · Period ending: · USD

KYMR logo

KYMR Investing Cash Flow

Latest reported$20.05M
KYMR Quarterly Cash from Investing (-$78.32M → $20.05M)
High-resolution chart · PNG

KYMR investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
20,045,000
-142,840,000
-394,398,000
-235,299,000
60,021,000
48,615,000
68,568,000
-157,680,000
15,642,000
-330,607,000
18,952,000
60,511,000
35,839,000
24,584,000
-49,666,000
-37,481,000
81,803,000
25,863,000
-68,019,000
-136,862,000
60,723,000
44,323,000
-3,990,000
-334,321,000
-46,874,000
-37,403,000
61,959,000
-78,323,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.